Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Loss of long-chain acyl-CoA dehydrogenase protects against acute kidney injury
Takuto Chiba, Akira Oda, Yuxun Zhang, Katherine Pfister, Joanna Bons, Sivakama S. Bharathi, Ayako Kinoshita, Bob B. Zhang, Adam Richert, Birgit Schilling, Eric Goetzman, Sunder Sims-Lucas
Takuto Chiba, Akira Oda, Yuxun Zhang, Katherine Pfister, Joanna Bons, Sivakama S. Bharathi, Ayako Kinoshita, Bob B. Zhang, Adam Richert, Birgit Schilling, Eric Goetzman, Sunder Sims-Lucas
View: Text | PDF
Research Article Metabolism Nephrology

Loss of long-chain acyl-CoA dehydrogenase protects against acute kidney injury

  • Text
  • PDF
Abstract

The renal tubular epithelial cells (RTECs) are particularly vulnerable to acute kidney injury (AKI). While fatty acids are the preferred energy source for RTECs via fatty acid oxidation (FAO), FAO-mediated H2O2 production in mitochondria has been shown to be a major source of oxidative stress. We have previously shown that a mitochondrial flavoprotein, long-chain acyl-CoA dehydrogenase (LCAD), which catalyzes a key step in mitochondrial FAO, directly produces H2O2 in vitro. Furthermore, we showed that renal LCAD becomes hyposuccinylated during AKI. Here, we demonstrated that succinylation of recombinant LCAD protein suppresses the production of H2O2. Following 2 distinct models of AKI, cisplatin treatment or renal ischemia/reperfusion injury (IRI), LCAD–/– mice demonstrated renoprotection. Specifically, LCAD–/– kidneys displayed mitigated renal tubular injury, decreased oxidative stress, preserved mitochondrial function, enhanced peroxisomal FAO, and decreased ferroptotic cell death. LCAD deficiency confers protection against 2 distinct models of AKI. This suggests a therapeutically attractive mechanism whereby preserved mitochondrial respiration as well as enhanced peroxisomal FAO by loss of LCAD mediates renoprotection against AKI.

Authors

Takuto Chiba, Akira Oda, Yuxun Zhang, Katherine Pfister, Joanna Bons, Sivakama S. Bharathi, Ayako Kinoshita, Bob B. Zhang, Adam Richert, Birgit Schilling, Eric Goetzman, Sunder Sims-Lucas

×

Figure 6

LCAD–/– kidneys preserve mitochondrial function in cisplatin-AKI.

Options: View larger image (or click on image) Download as PowerPoint

LCAD–/– kidneys preserve mitochondrial function in cisplatin-AKI.
(A) O...
(A) Oroboros O2k respirometry revealed that Complex I of the electron transport chain was increased in LCAD–/– kidneys compared with WT 3 days after cisplatin treatment. (B) mtDNA levels are increased in LCAD–/– kidneys. (C) LCAD–/– kidneys increased immunoblotted succinate dehydrogenase complex flavoprotein subunit A (SDHA) expression in whole kidney lysates 3 days after cisplatin treatment. A representative blot image and the quantified data for cisplatin treated samples are shown. (D) Immunostained SDHA in whole kidneys of WT versus LCAD–/– 3 days after cisplatin treatment. Scale bars: 50 μm. *P < 0.05; ****P < 0.0001, using 1-way ANOVA post hoc Tukey multiple comparison (A) or t test (B and C).

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts